Dr Reddys Laboratories Share Price Today - Live Blog for October 31, 2025

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.13% increase and currently trading at ₹1,199.10 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd shares experienced a -0.04% reduction, with the current market price at ₹1,197.45. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd experienced a -0.04% dip in its share price and is currently trading at ₹1,197.45. The stock has a PE ratio of 17.4900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd share price surged by 0.24%. With its current market price standing at ₹1,197.95 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd witnessed a substantial 0.03% increase in its share price and is currently trading at ₹1,194.90. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd witnessed a -0.00% drop in its share price and is currently trading at ₹1,194.60. With the stock's PE at 17.4900 and the industry PE at 34.9956, investors are weighing their options.

Dr Reddys Laboratories Ltd experienced a -0.00% downturn in its share price, and it's currently trading at ₹1,194.60. This situation is generating interest among value investors who are evaluating the stock's potential.

The stock of Dr Reddys Laboratories Ltd is facing a -0.05% decline and is currently trading at ₹1,194.25 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd shares experienced a -0.05% reduction, with the current market price at ₹1,194.25. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.05% drop, and it's now trading at ₹1,194.25 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd shares saw a -0.05% decrease, reaching a current market price of ₹1,194.25. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.4900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd share price has declined by -0.07%, and it's currently trading at ₹1,194.35. The stock maintains a PE of 17.4900, while the industry PE is 34.9956, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd witnessed a -0.02% decrease in its share price, and it is currently trading at ₹1,195.20. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.4900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,195.20. This development raises questions about the factors behind the decline. The stock's PE ratio is 17.4900, while the industry PE is 34.9956.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.06% gain, with the share price now at ₹1,195.70. Notably, the stock's PE ratio stands at 17.4900, and its Return on Equity (ROE) is 16.0277%.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.06%, reaching the current market price of ₹1,195.70. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Following a noteworthy 0.08% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,194.55. When it comes to valuation, this stock has a PE ratio of 17.4900, with the industry PE ratio at 34.9956.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.05%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,192.60 per share.

The stock of Dr Reddys Laboratories Ltd is facing a -0.05% decline and is currently trading at ₹1,192.55 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

After a -0.03% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,193.00. The stock has a PE ratio of 17.4900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd suffered a -0.02% drop, and it's now trading at ₹1,193.20 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd observed a -0.10% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,193.20. The stock has a PE ratio of 17.4900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd share price has declined by -0.09%, and it's currently trading at ₹1,194.40. The stock maintains a PE of 17.4900, while the industry PE is 34.9956, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.09% drop, and it's now trading at ₹1,194.40 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd stock price decreased by -0.09%, with the current market value at ₹1,194.40 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd experienced a -0.09% dip in its share price and is currently trading at ₹1,194.40. The stock has a PE ratio of 17.4900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd remained stagnant, with no fluctuations. It is currently at ₹1,195.00. Investors may use this stability as an opportunity to reevaluate their portfolios and risk tolerance.

There were no changes in the share price of Dr Reddys Laboratories Ltd, which is currently at ₹1,195.00. During this period of price stability, investors may review the stock's financials and market positioning.

Dr Reddys Laboratories Ltd's share price remained steady, showing no variations, and is currently at ₹1,195.00. While the stock's performance remains consistent, it's worth noting that its PE ratio is 17.4900, while the industry PE is 34.9956.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.29% drop, and it's now trading at ₹1,196.10 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd witnessed a -0.29% decrease in its share price, and it is currently trading at ₹1,196.10. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.4900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.23% upswing and is currently trading at ₹1,199.00, indicating strong market sentiment.

The share price of Dr Reddys Laboratories Ltd plunged by -0.23%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,197.20, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd experienced a -0.05% dip in its share price and is currently trading at ₹1,199.40. The stock has a PE ratio of 17.4900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.03%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,200.00, and market participants are assessing the implications. The stock has a PE ratio of 17.4900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd share price has declined by -0.15%, and it's currently trading at ₹1,201.20. The stock maintains a PE of 17.4900, while the industry PE is 34.9956, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd's share price rallied by 2.68%, reaching the current market price of ₹1,201.30. This surge is indicative of the stock's recent positive performance.